BFC Planning’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.62K Buy
113
+21
+23% +$776 ﹤0.01% 2814
2026
Q2
$3.56K Hold
92
– – ﹤0.01% 2808
2026
Q1
$3.54K Buy
+92
New +$3.4K ﹤0.01% 2433

Other funds holding COGT

BFC Planning's COGT Position: Q3 2026 in Review

BFC Planning increased its Cogent Biosciences (COGT) stake by 23% in Q3 2026, buying an estimated $776 and bringing the position to 113 shares worth $3.62K. The position accounts for ﹤0.01% of the portfolio, ranked #2814.

BFC Planning first reported a position in COGT in Q1 2026 and has held it in 3 quarters since. 202 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • BFC Planning held 113 shares of Cogent Biosciences worth $3.62K as of Q3 2026.
  • BFC Planning bought 21 Cogent Biosciences shares in Q3 2026, an estimated $776.
  • Cogent Biosciences made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2814 holding.
  • BFC Planning first reported a position in Cogent Biosciences in Q1 2026 and has held it in 3 quarters since.
  • 202 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.